Atrium Therapeutics Inc (RNA)

R&D Expense Growth

-7.89%

Quarterly · Period ending:

RNA logo

RNA R&D Expense Growth

Latest reported-7.89%
RNA Quarterly R&D Growth (QoQ) (0.00% → -7.89%)
High-resolution chart · PNG

RNA r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-7.8886%
-9.9476%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.